We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$2.85B
AUM Growth
+$169M
Cap. Flow
+$16.4M
Cap. Flow %
0.58%
Top 10 Hldgs %
65.16%
Holding
451
New
10
Increased
153
Reduced
16
Closed
14

Top Buys

Rank Stock Value
1
IT icon
Gartner
IT
+$5.11M
2
LMND icon
Lemonade
LMND
+$4.4M
3
TTD icon
Trade Desk
TTD
+$3.52M
4
BSX icon
Boston Scientific
BSX
+$2.93M
5
TRP icon
TC Energy
TRP
+$2.69M

Sector Composition

Rank Sector Weight
1 Healthcare 46.71%
2 Consumer Discretionary 8.55%
3 Technology 8.03%
4 Communication Services 7.66%
5 Financials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESE icon
251
ESCO Technologies
ESE
$8.15B
$130K ﹤0.01%
1,190
NVST icon
252
Envista
NVST
$4.46B
$129K ﹤0.01%
3,150
BOOM icon
253
DMC Global
BOOM
$137M
$128K ﹤0.01%
2,362
VMC icon
254
Vulcan Materials
VMC
$35.1B
$127K ﹤0.01%
753
XLF icon
255
State Street Financial Select Sector SPDR ETF
XLF
$56.8B
$127K ﹤0.01%
3,739
+17
+0.5% +$546
OLN icon
256
Olin
OLN
$2.13B
$125K ﹤0.01%
3,282
+21
+0.6% +$636
SAH icon
257
Sonic Automotive
SAH
$2.9B
$122K ﹤0.01%
2,455
CCI icon
258
Crown Castle
CCI
$33.3B
$121K ﹤0.01%
705
+5
+0.7% +$801
CWST icon
259
Casella Waste Systems
CWST
$5.65B
$121K ﹤0.01%
1,910
PSXP
260
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
$121K ﹤0.01%
3,826
XLRN
261
DELISTED
Acceleron Pharma
XLRN
$119K ﹤0.01%
880
QTS
262
DELISTED
QTS REALTY TRUST, INC.
QTS
$119K ﹤0.01%
1,920
FUL icon
263
H.B. Fuller
FUL
$2.96B
$118K ﹤0.01%
1,870
ICLR icon
264
Icon
ICLR
$12.8B
$115K ﹤0.01%
584
CVBF icon
265
CVB Financial
CVBF
$3.95B
$114K ﹤0.01%
5,170
MTRN icon
266
Materion
MTRN
$4.43B
$113K ﹤0.01%
1,713
GPN icon
267
Global Payments
GPN
$23.2B
$110K ﹤0.01%
546
+1
+0.2% +$199
ACIW icon
268
ACI Worldwide
ACIW
$5.86B
$109K ﹤0.01%
2,860
DAN icon
269
Dana Inc
DAN
$2.88B
$108K ﹤0.01%
4,440
+20
+0.5% +$458
FHN icon
270
First Horizon
FHN
$12.2B
$108K ﹤0.01%
6,370
ITGR icon
271
Integer Holdings
ITGR
$3.43B
$108K ﹤0.01%
1,170
AMN icon
272
AMN Healthcare
AMN
$1.31B
$107K ﹤0.01%
1,455
CEVA icon
273
CEVA Inc
CEVA
$921M
$107K ﹤0.01%
1,908
FWRD icon
274
Forward Air
FWRD
$452M
$107K ﹤0.01%
1,210
IBM icon
275
IBM
IBM
$209B
$107K ﹤0.01%
837

Similar funds

Bollard Group's Q1 2021 Portfolio in Review

As of Q1 2021, Bollard Group held 451 positions worth $2.85B, up 6.3% from $2.69B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Bollard Group's Q1 2021 filing shows 10 new, 153 increased, 16 reduced and 14 closed positions. Its largest new stake was Lemonade: 34,100 shares worth $3.18M. The largest sale was DraftKings, an estimated $25M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 46% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bollard Group's largest Q1 2021 buy was Lemonade: 34,100 shares worth $3.18M.
  • Bollard Group added most to Gartner in Q1 2021, an estimated $5.11M increase.
  • Bollard Group's biggest Q1 2021 reduction was Eli Lilly, cutting an estimated $4.8M.
  • Bollard Group fully exited DraftKings in Q1 2021, selling an estimated $25M.
  • Bollard Group's ten largest holdings make up 65% of its $2.85B portfolio in Q1 2021.
  • Bollard Group opened 10 new positions and closed 14 in Q1 2021.
  • Bollard Group's portfolio value rose 6.3% quarter-over-quarter to $2.85B.

Based on Bollard Group's 13F filing for Q1 2021, filed 11 May 2021.